|
EP1309341A2
(en)
|
2000-07-07 |
2003-05-14 |
Lars Lannfelt |
Prevention and treatment of alzheimer's disease
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
|
ES2432112T3
(es)
|
2004-02-10 |
2013-11-29 |
The Regents Of The University Of Colorado, A Body Corporate |
Inhibición del factor B, de la vía alternativa del complemento y métodos relacionados
|
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
US7780963B2
(en)
*
|
2004-10-25 |
2010-08-24 |
Merck & Co., Inc. |
Anti-ADDL antibodies and uses thereof
|
|
US20060134098A1
(en)
|
2004-11-16 |
2006-06-22 |
Kalobios, Inc. |
Immunoglobulin variable region cassette exchange
|
|
US7906625B2
(en)
*
|
2005-01-24 |
2011-03-15 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
|
CA2610340C
(en)
|
2005-05-26 |
2016-02-16 |
Vernon Michael Holers |
Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions
|
|
EP1929306A4
(en)
*
|
2005-09-01 |
2009-11-11 |
Precision Therapeutics Inc |
CHEMOSENSIBLE ASSAYS, THE TUMOR CELLS WITH PERSISTENT PHENOTYPICAL CHARACTERISTICS
|
|
CA2626783A1
(en)
*
|
2005-10-21 |
2007-05-03 |
Merck & Co., Inc. |
Anti-addl monoclonal antibody and use thereof
|
|
CA2630964A1
(en)
*
|
2005-11-22 |
2007-05-31 |
The Trustees Of The University Of Pennsylvania |
Antibody treatment of alzheimer's and related diseases
|
|
RU2432362C2
(ru)
|
2005-11-30 |
2011-10-27 |
Эбботт Лэборетриз |
Моноклональные антитела и их применения
|
|
PL2289909T3
(pl)
|
2005-11-30 |
2015-04-30 |
Abbvie Inc |
Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał
|
|
UA102368C2
(ru)
*
|
2005-12-12 |
2013-07-10 |
Ас Иммуне С.А. |
СПЕЦИФИЧЕСКИЕ В ОТНОШЕНИИ β-АМИЛОИДА 1-42 МОНОКЛОНАЛЬНЫЕ АНТИТЕЛА, КОТОРЫЕ ИМЕЮТ ТЕРАПЕВТИЧЕСКИЕ СВОЙСТВА
|
|
SG10201404801YA
(en)
|
2005-12-12 |
2014-09-26 |
Ac Immune Sa |
Monoclonal antibody
|
|
EA014531B1
(ru)
*
|
2006-02-24 |
2010-12-30 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Антиамилоидные иммуногенные композиции, способы и применения
|
|
RU2429244C2
(ru)
|
2006-03-23 |
2011-09-20 |
Байоарктик Ньюросайенс Аб |
Улучшенные селективные в отношении протофибрилл антитела и их применение
|
|
EP3988566A1
(en)
*
|
2006-07-14 |
2022-04-27 |
AC Immune SA |
Humanized antibody against amyloid beta
|
|
NZ574188A
(en)
*
|
2006-07-14 |
2012-05-25 |
Ac Immune Sa |
Humanized antibody against amyloid beta
|
|
LT2468770T
(lt)
*
|
2006-07-14 |
2018-05-25 |
Ac Immune S.A. |
Humanizuotas antikūnas prieš beta amiloidą
|
|
KR20150002879A
(ko)
*
|
2006-10-02 |
2015-01-07 |
에이씨 이뮨 에스.에이. |
아밀로이드 베타에 대해 인간화된 항체
|
|
WO2008060814A2
(en)
*
|
2006-10-19 |
2008-05-22 |
Merck & Co., Inc. |
ANTI-IL-13Rα1 ANTIBODIES AND THEIR USES THEREOF
|
|
JP2010507366A
(ja)
*
|
2006-10-19 |
2010-03-11 |
メルク アンド カンパニー インコーポレイテッド |
インターロイキン−１３受容体α１の抗体アンタゴニスト
|
|
CN101588816B
(zh)
*
|
2006-10-19 |
2013-06-19 |
Csl有限公司 |
白介素-13受体α1的高亲和性抗体拮抗物
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
JP2010515717A
(ja)
|
2007-01-11 |
2010-05-13 |
フィリップス−ウニベルジテート・マールブルク |
アルツハイマーおよび他の神経性認知症疾患の診断ならびに処置
|
|
EP2124952A2
(en)
|
2007-02-27 |
2009-12-02 |
Abbott GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
AU2008220785B2
(en)
|
2007-03-01 |
2013-02-21 |
Vivoryon Therapeutics N.V. |
New use of glutaminyl cyclase inhibitors
|
|
CA2680344A1
(en)
|
2007-03-14 |
2008-11-20 |
Woodruff Emlen |
Humaneered anti-factor b antibody
|
|
JP5667440B2
(ja)
|
2007-04-18 |
2015-02-12 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
|
|
CA2689120C
(en)
*
|
2007-06-04 |
2017-07-11 |
Vib Vzw |
Targeted induction of aggregation of proteins with cross beta structures
|
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
|
EP2009445A1
(en)
*
|
2007-06-29 |
2008-12-31 |
Institut Pasteur |
Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications
|
|
US8962677B2
(en)
|
2007-07-12 |
2015-02-24 |
Acumen Pharmaceuticals, Inc. |
Methods of restoring cognitive ability using non-peptidic compounds
|
|
US9006283B2
(en)
|
2007-07-12 |
2015-04-14 |
Acumen Pharmaceuticals, Inc. |
Methods of modifying amyloid β oligomers using non-peptidic compounds
|
|
RS53174B
(sr)
|
2007-10-05 |
2014-06-30 |
Genentech Inc. |
Upotreba antiamiloidnog beta antitela u slučaju oboljenja oka
|
|
CA2701788C
(en)
*
|
2007-10-05 |
2017-06-13 |
Genentech, Inc. |
Humanized beta-amyloid antibody for treating ocular diseases
|
|
US20090104210A1
(en)
*
|
2007-10-17 |
2009-04-23 |
Tota Michael R |
Peptide compounds for treating obesity and insulin resistance
|
|
JPWO2009051220A1
(ja)
*
|
2007-10-19 |
2011-03-03 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
PT3002298T
(pt)
|
2007-11-21 |
2019-11-20 |
Univ Oregon Health & Science |
Anticorpos monoclonais anti-fator xi e métodos de utilização dos mesmos
|
|
WO2009079566A2
(en)
|
2007-12-18 |
2009-06-25 |
Acumen Pharmaceuticals, Inc. |
Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
|
|
WO2009085200A2
(en)
|
2007-12-21 |
2009-07-09 |
Amgen Inc. |
Anti-amyloid antibodies and uses thereof
|
|
HUE031944T2
(en)
*
|
2008-02-08 |
2017-08-28 |
Immunas Pharma Inc |
Antibodies capable of specific binding of amyloid β-oligomers and their use
|
|
AT506819B1
(de)
|
2008-06-12 |
2011-06-15 |
Affiris Forschungs Und Entwicklungs Gmbh |
Vakzin zur behandlung von alzheimer-krankheit
|
|
US9085614B2
(en)
|
2008-08-01 |
2015-07-21 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to Aβ oligomers and uses thereof
|
|
EP2321338A1
(en)
*
|
2008-08-14 |
2011-05-18 |
Merck Sharp & Dohme Corp. |
Methods for purifying antibodies using protein a affinity chromatography
|
|
CN102459335B
(zh)
|
2009-04-17 |
2015-11-25 |
伊缪纳斯制药株式会社 |
特异性结合Aβ寡聚体的抗体及其用途
|
|
JP5871798B2
(ja)
|
2009-07-02 |
2016-03-01 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
肝再生を刺激する方法
|
|
JP5599454B2
(ja)
*
|
2009-08-06 |
2014-10-01 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
ES2624835T3
(es)
*
|
2009-08-06 |
2017-07-17 |
Immunas Pharma, Inc. |
Anticuerpos que se unen específicamente a los oligómeros A beta y uso de los mismos
|
|
PL2463368T3
(pl)
|
2009-08-07 |
2018-07-31 |
Kyowa Hakko Kirin Co., Ltd. |
Humanizowane przeciwciało anty-oligomer amyloidu B
|
|
CN102597233B
(zh)
*
|
2009-08-07 |
2014-10-29 |
协和发酵麒麟株式会社 |
人源化抗淀粉样-b寡聚体抗体
|
|
EP2473531A4
(en)
*
|
2009-09-03 |
2013-05-01 |
Merck Sharp & Dohme |
Anti-gitr antibodies
|
|
JP5934645B2
(ja)
|
2009-09-11 |
2016-06-15 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
|
|
WO2011065305A1
(ja)
*
|
2009-11-24 |
2011-06-03 |
楽天株式会社 |
情報処理装置、情報処理方法、プログラム及び記憶媒体
|
|
ES2751549T3
(es)
|
2009-11-30 |
2020-04-01 |
Janssen Biotech Inc |
Mutantes de anticuerpos Fc con funciones efectoras ablacionadas
|
|
US10053513B2
(en)
|
2009-11-30 |
2018-08-21 |
Janssen Biotech, Inc. |
Antibody Fc mutants with ablated effector functions
|
|
CN103037900B
(zh)
|
2010-02-24 |
2016-04-06 |
伊缪诺金公司 |
叶酸受体1抗体与免疫缀合物以及其用途
|
|
WO2011107530A2
(en)
|
2010-03-03 |
2011-09-09 |
Probiodrug Ag |
Novel inhibitors
|
|
JP5688745B2
(ja)
|
2010-03-10 |
2015-03-25 |
プロビオドルグ エージー |
グルタミニルシクラーゼ（ｑｃ、ｅｃ２．３．２．５）の複素環阻害剤
|
|
ES2684475T3
(es)
|
2010-04-15 |
2018-10-03 |
Abbvie Inc. |
Proteínas que se unen a beta amiloide
|
|
WO2011131748A2
(en)
|
2010-04-21 |
2011-10-27 |
Probiodrug Ag |
Novel inhibitors
|
|
WO2011149461A1
(en)
|
2010-05-27 |
2011-12-01 |
Medtronic, Inc. |
Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules
|
|
CA2805414C
(en)
*
|
2010-07-14 |
2020-07-07 |
Merck Sharp & Dohme Corp. |
Anti-addl monoclonal antibody and uses thereof
|
|
US9176151B2
(en)
|
2010-07-14 |
2015-11-03 |
Acumen Pharmaceuticals, Inc. |
Antibodies, kit and method for detecting amyloid beta oligomers
|
|
US9320793B2
(en)
|
2010-07-14 |
2016-04-26 |
Acumen Pharmaceuticals, Inc. |
Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42
|
|
RU2607368C2
(ru)
|
2010-07-30 |
2017-01-10 |
Ац Иммуне С.А. |
Безопасные и функциональные гуманизированные антитела
|
|
CN103298833B
(zh)
|
2010-08-14 |
2015-12-16 |
Abbvie公司 |
β淀粉样蛋白结合蛋白
|
|
WO2012032520A1
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
|
EP2621947A1
(en)
*
|
2010-09-27 |
2013-08-07 |
Zestagen, S.A. |
Compositions and methods for treating neoplasia
|
|
ES2548686T3
(es)
*
|
2010-10-07 |
2015-10-20 |
Ac Immune S.A. |
Anticuerpos que reconocen fosfo-Tau
|
|
SG10201509499RA
(en)
*
|
2010-11-19 |
2015-12-30 |
Eisai R&D Man Co Ltd |
Neutralizing anti-ccl20 antibodies
|
|
EP2686313B1
(en)
|
2011-03-16 |
2016-02-03 |
Probiodrug AG |
Benzimidazole derivatives as inhibitors of glutaminyl cyclase
|
|
IL281714B2
(en)
|
2011-04-01 |
2023-11-01 |
Immunogen Inc |
Methods for increasing the effectiveness of FOLR1 cancer therapy
|
|
AU2012282825B2
(en)
|
2011-07-13 |
2016-05-26 |
Merck Sharp & Dohme Corp. |
Method for detection of amyloid beta oligomers in a fluid sample and uses thereof
|
|
GB201112056D0
(en)
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
|
ES2925654T3
(es)
|
2011-09-30 |
2022-10-19 |
Dana Farber Cancer Inst Inc |
Péptidos terapéuticos que comprenden anticuerpos que se unen a la secuencia A relacionada con el polipéptido del CMH de clase I (MICA)
|
|
EP2766094B1
(en)
*
|
2011-10-10 |
2019-03-06 |
Lancaster University Business Enterprises Limited |
Compositions for binding to amyloid proteins
|
|
SG10201604104PA
(en)
|
2011-10-25 |
2016-07-28 |
Prothena Therapeutics Ltd |
Antibody formulations and methods
|
|
DE102011057019A1
(de)
*
|
2011-12-23 |
2013-06-27 |
Forschungszentrum Jülich GmbH |
Standard zur Quantifizierung von pathogenen Aggregaten aus körpereigenen Proteinen
|
|
WO2013164763A2
(en)
|
2012-04-30 |
2013-11-07 |
Innovative Health Diagnostics |
A biological complex specific for alzheimer's disease detection in vitro and use thereof
|
|
WO2013168164A1
(en)
|
2012-05-09 |
2013-11-14 |
Yeda Research And Development Co. Ltd. |
Variants of tace pro-domain as tnf-a inhibitor and their medical use
|
|
EP2855529A4
(en)
|
2012-05-24 |
2015-12-09 |
Alexion Pharma Inc |
HUMANIZED ANTI-FACTOR B ANTIBODIES
|
|
HUE049693T2
(hu)
|
2012-08-31 |
2020-10-28 |
Immunogen Inc |
Diagnosztikai ASSAY-k és készletek a folát receptor 1 kimutatására
|
|
KR20150130462A
(ko)
|
2013-03-15 |
2015-11-23 |
다나-파버 캔서 인스티튜트 인크. |
치료 펩티드
|
|
AU2014312086B2
(en)
|
2013-08-30 |
2020-03-12 |
Immunogen, Inc. |
Antibodies and assays for detection of folate receptor 1
|
|
HRP20200384T1
(hr)
|
2013-12-20 |
2020-06-12 |
F. Hoffmann - La Roche Ag |
Humanizirana anti-tau(ps422) protutijela i načini uporabe
|
|
WO2015139020A2
(en)
|
2014-03-14 |
2015-09-17 |
Dana-Farber Cancer Institute, Inc. |
Vaccine compositions and methods for restoring nkg2d pathway function against cancers
|
|
AR100978A1
(es)
|
2014-06-26 |
2016-11-16 |
Hoffmann La Roche |
LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS
|
|
EP3166970B1
(en)
*
|
2014-07-10 |
2021-03-10 |
BioArctic AB |
Improved a-beta protofibril binding antibodies
|
|
WO2016160620A2
(en)
*
|
2015-03-27 |
2016-10-06 |
University Of Southern California |
Car t-cells for the treatment of b7-h4 expressing solid tumors
|
|
AU2016243124A1
(en)
|
2015-03-27 |
2017-11-02 |
University Of Southern California |
CAR T-cell therapy directed to LHR for the treatment of solid tumors
|
|
CN107810196B
(zh)
|
2015-06-24 |
2021-11-05 |
豪夫迈·罗氏有限公司 |
人源化的抗-Tau(pS422)抗体和使用方法
|
|
AU2016323968B2
(en)
|
2015-09-17 |
2023-07-06 |
Immunogen, Inc. |
Therapeutic combinations comprising anti-FOLR1 immunoconjugates
|
|
JP2017132742A
(ja)
*
|
2016-01-29 |
2017-08-03 |
国立大学法人 大分大学 |
Ａβオリゴマー特異的抗体の新規薬理用途
|
|
US10899839B2
(en)
|
2016-03-28 |
2021-01-26 |
Tire Regents of the University of California |
Anti-Ryk antibodies and methods of using the same
|
|
CN110325547B
(zh)
|
2016-11-07 |
2023-12-26 |
德格克斯有限公司 |
新淀粉样蛋白β寡聚体特异性结合分子
|
|
EP3562506A4
(en)
|
2016-12-29 |
2021-01-06 |
University of Miami |
METHOD TO MODULATE INFLAMMASOME ACTIVITY AND INFLAMMATION IN THE LUNG
|
|
US11840565B2
(en)
|
2016-12-29 |
2023-12-12 |
University Of Miami |
Methods and compositions for treating virus-associated inflammation
|
|
ES2984844T3
(es)
*
|
2017-07-18 |
2024-10-31 |
Univ British Columbia |
Anticuerpos contra beta amiloide
|
|
AU2018308088B2
(en)
|
2017-07-25 |
2025-05-29 |
Truebinding, Inc. |
Treating cancer by blocking the interaction of TIM-3 and its ligand
|
|
CA3070295A1
(en)
*
|
2017-07-28 |
2019-01-31 |
Phanes Therapeutics, Inc. |
Anti-tim-3 antibodies and uses thereof
|
|
ES2812698T3
(es)
|
2017-09-29 |
2021-03-18 |
Probiodrug Ag |
Inhibidores de glutaminil ciclasa
|
|
WO2019155459A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Inhibitors of the 20s proteasome
|
|
WO2020010273A1
(en)
*
|
2018-07-03 |
2020-01-09 |
University Of Miami |
Compositions and methods for treating inflammasome related diseases or conditions
|
|
CA3106116A1
(en)
*
|
2018-07-17 |
2020-01-23 |
Jiangsu Hengrui Medicine Co., Ltd. |
Anti-abeta antibody, antigen-binding fragment thereof and application thereof
|
|
CN111217912B
(zh)
*
|
2018-11-26 |
2022-11-08 |
东莞市朋志生物科技有限公司 |
一种抗pgⅱ的抗体及其应用
|
|
WO2020123492A1
(en)
*
|
2018-12-10 |
2020-06-18 |
New York University |
Monoclonal antibodies targeting c-terminal region of phosphorylated tau
|
|
AU2020214796A1
(en)
|
2019-01-30 |
2021-07-29 |
Truebinding, Inc. |
Anti-Gal3 antibodies and uses thereof
|
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Preparations containing the propeptide of lysyl oxidase and their uses
|
|
EP3986932A1
(en)
*
|
2019-06-21 |
2022-04-27 |
Università Degli Studi Magna Graecia Catanzaro |
Monoclonal antibody targeting a unique cancer-associated epitope of cd43
|
|
US20220268789A1
(en)
*
|
2019-07-05 |
2022-08-25 |
Shimadzu Corporation |
Monoclonal antibody against amyloid beta, and method for measuring amyloid beta-related peptide using said antibody
|
|
MX2022002873A
(es)
*
|
2019-09-10 |
2022-03-25 |
Ac Immune Sa |
Nuevas moleculas para diagnostico.
|
|
WO2021055670A1
(en)
|
2019-09-20 |
2021-03-25 |
Avx Corporation |
Somatic cell-based electrical biosensor
|
|
AU2021238320A1
(en)
*
|
2020-03-18 |
2022-09-22 |
Elanco Us Inc. |
Anti-IL4 receptor antibodies for veterinary use
|
|
WO2021242776A2
(en)
|
2020-05-26 |
2021-12-02 |
Truebinding, Inc. |
Methods of treating inflammatory diseases by blocking galectin-3
|
|
CN112480250B
(zh)
*
|
2020-12-23 |
2022-03-15 |
上海交通大学 |
一种抗人骨桥蛋白的抗体及其应用
|
|
TW202300517A
(zh)
|
2021-03-12 |
2023-01-01 |
美商美國禮來大藥廠 |
抗類澱粉β抗體及其用途
|
|
WO2022251048A1
(en)
|
2021-05-24 |
2022-12-01 |
Eli Lilly And Company |
Anti-amyloid beta antibodies and uses thereof
|
|
WO2023034324A2
(en)
*
|
2021-08-30 |
2023-03-09 |
The Brigham And Women’S Hospital, Inc. |
Methods and materials to treat neurodegenerative disease
|
|
JP2024540694A
(ja)
*
|
2021-11-03 |
2024-10-31 |
ラトガース ザ ステイト ユニバーシティー オブ ニュージャージー |
受容体型チロシンキナーゼＥｐｈＡ５に対する抗体－薬物コンジュゲート
|
|
WO2023122555A2
(en)
*
|
2021-12-21 |
2023-06-29 |
Hbvtech, Llc. |
Methods for eliminating hepatitis b virus cccdna and rcdna and the hepatitis b drugs used in the methods thereof
|
|
EP4479075A1
(en)
|
2022-02-17 |
2024-12-25 |
Yeda Research and Development Co. Ltd |
Propeptide of lysyl oxidase for treatment of cancer
|
